DBV Technologies (DBVT) Current Leases (2019 - 2026)
DBV Technologies (DBVT) posted Current Leases of $800000.0 for Q2 2026, down 20.0% sequentially from $1.0 million in Q1 2026, and down 19.84% YoY from $998000.0 in Q2 2025.
DBV Technologies (DBVT) Current Leases (2019 - 2026) Analysis & Trends
DBV Technologies has reported Current Leases for 8 years, with the latest figure at $800000.0 in Q2 2026.
- Quarterly Current Leases fell 19.84% year-over-year to $800000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $800000.0 (down 19.84% YoY) and the FY2025 annual result came in at $1.1 million, up 68.2% from the prior year.
- Current Leases fell to $800000.0 in Q2 2026 per DBVT's latest filing, from $1.0 million in the prior quarter.
- Over five years, Current Leases peaked at $2.0 million in Q1 2022 and troughed at $232000.0 in Q1 2024.
- A 5-year average of $1.2 million and a median of $1.1 million in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2024 and 2025: Current Leases sank 87.94% in 2024, then surged 205.6% in 2025.
- Over 5 years, Current Leases stood at $1.9 million in 2022, then slumped by 39.6% to $1.1 million in 2023, then sank by 42.83% to $654000.0 in 2024, then jumped by 68.2% to $1.1 million in 2025, then decreased by 27.27% to $800000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $800000.0, $1.0 million, and $1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - | 800,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 800,000.00 |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 998,000.00 |
| Mar 31, 2025 | 709,000.00 |
| Dec 31, 2024 | 654,000.00 |
| Sep 30, 2024 | 374,000.00 |
| Jun 30, 2024 | 380,000.00 |
| Mar 31, 2024 | 232,000.00 |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.94 Mn |
| Mar 31, 2023 | 1.92 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 1.97 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 2.66 Mn |